admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Question 4 Fails: Massachusetts Says No to State-Regulated Psychedelics Access and...

Ketamine-Assisted Therapy at Work? The Future of Employee Benefits

Psychedelics on the Ballot 2024

Bipartisan Momentum or Radical Reform? Insiders Weigh In on the Future...

Psychedelics Advocates Urge Yes on Question 4 Amid Last-Minute Debates

Psychedelics Lately – Massachusetts’ Question 4 and Updates in Psychedelics and...

OP-Ed: From a Massachusetts Psychiatrist: Why Doctors Support Yes on Question...

Pα+ Psychedelic Bulletin #179: VA Funds MDMA for PTSD and AUD...

Is Cannabis Psychedelic? Examining the Scientific Evidence

Backed by $15m in NIDA Funding, NYU and B.More Team Up...

1...567...218 Page 6 of 218

EDITOR PICKS

UK Psychedelic Research Hindered by Red Tape, Experts Tell Lawmakers in...

MDMA for Active-Duty Troops: Aaron Wolfgang on DoD’s Unprecedented Study

Opinions: PrEP’s Rollout Offers a Roadmap for Prescription Psychedelics

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin